Bob Murray

Director, Rare Disease Insights at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Bob Murray's Colleagues at Alnylam Pharmaceuticals
Kate Gilling

Medical Science Liaison

Contact Kate Gilling

Cheryl Riel

Director, Nonclinical Writing and Document Management

Contact Cheryl Riel

Sandeep Duttagupta

Vice President, Global Pricing & Market Access

Contact Sandeep Duttagupta

Kimberly Harding

Senior Associate Scientist- EDEV Histopathology

Contact Kimberly Harding

View All Bob Murray's Colleagues
Bob Murray's Contact Details
HQ
(617) 551-8200
Location
Cambridge,Massachusetts,United States
Company
Alnylam Pharmaceuticals
Bob Murray's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Bob Murray
Bob Murray currently works for Alnylam Pharmaceuticals.
Bob Murray's role at Alnylam Pharmaceuticals is Director, Rare Disease Insights.
Bob Murray's email address is ***@alnylam.com. To view Bob Murray's full email address, please signup to ConnectPlex.
Bob Murray works in the SaaS industry.
Bob Murray's colleagues at Alnylam Pharmaceuticals are Patrick Jay, Yanjie Jiang, Kate Gilling, Cheryl Riel, Babak Basiri, Sandeep Duttagupta, Kimberly Harding and others.
Bob Murray's phone number is (617) 551-8200
See more information about Bob Murray